Cargando…
ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer
Treatment with androgen receptor pathway inhibitors (ARPIs) in prostate cancer leads to the emergence of resistant tumors characterized by lineage plasticity and differentiation toward neuroendocrine lineage. Here, we find that ARPIs induce a rapid epigenetic alteration mediated by large-scale chrom...
Autores principales: | Nouruzi, Shaghayegh, Ganguli, Dwaipayan, Tabrizian, Nakisa, Kobelev, Maxim, Sivak, Olena, Namekawa, Takeshi, Thaper, Daksh, Baca, Sylvan C., Freedman, Matthew L., Aguda, Adeleke, Davies, Alastair, Zoubeidi, Amina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046280/ https://www.ncbi.nlm.nih.gov/pubmed/35477723 http://dx.doi.org/10.1038/s41467-022-29963-5 |
Ejemplares similares
-
Galiellalactone inhibits the STAT3/AR signaling axis and suppresses Enzalutamide-resistant Prostate Cancer
por: Thaper, Daksh, et al.
Publicado: (2018) -
The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer
por: Bishop, Jennifer L., et al.
Publicado: (2014) -
Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer
por: Vahid, Sepideh, et al.
Publicado: (2016) -
Transcription factor ASCL2 is required for development of the glycogen trophoblast cell lineage
por: Bogutz, Aaron B., et al.
Publicado: (2018) -
Oligodendrocyte development in the embryonic tuberal hypothalamus and the influence of Ascl1
por: Marsters, Candace M., et al.
Publicado: (2016)